Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2016-03-17 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第五届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by 嘉事堂药业股份有限公司. It details the approval of a proposal to use idle raised funds temporarily to supplement working capital. The document includes voting results and references to related announcements published on other platforms. It does not contain financial statements or detailed financial analysis, nor is it a report or presentation. The content is about a board decision and related disclosures, fitting the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2016-03-17 Chinese
华泰联合证券有限责任公司关于公司使用闲置募集资金暂时补充流动资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion letter from the sponsor (华泰联合证券有限责任公司) regarding the use of idle raised funds by 嘉事堂药业股份有限公司 to temporarily supplement working capital. It references the non-public issuance of shares in 2015, the amount of funds raised, and the intended use of those funds. The document includes a due diligence investigation and compliance with regulatory requirements, concluding with the sponsor's approval and ongoing monitoring commitment. It is not a full financial report, earnings release, or regulatory filing but a formal audit/opinion related to the use of raised funds. The document length is 2673 characters, which is relatively short but contains substantive content and detailed analysis, not just an announcement or certification. This fits the category of an Audit Report / Information (AR), as it involves verification and opinion on the use of funds raised, consistent with audit or sponsor review reports on capital usage and compliance. Q1 2016
2016-03-17 Chinese
关于使用闲置募集资金暂时补充流动资金的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 嘉事堂药业股份有限公司 regarding the temporary use of idle raised funds to supplement working capital. It details the background of the fundraising, the amount raised, the intended projects, and the board's approval of using part of the idle funds for working capital temporarily. The document includes references to regulatory approvals, board and supervisory committee meetings, and independent opinions. The length is about 3100 characters, which is relatively short and the content is focused on a specific financing use announcement rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it is not an Annual Report (10-K), Interim Report (IR), or Audit Report (AR). It is also not a Capital/Financing Update (CAP) in the sense of new fundraising or capital structure changes, but rather an announcement about the use of already raised funds. This fits best with a Regulatory Filing (RNS) as a general regulatory announcement about the use of funds and compliance with regulations. The document is not a report publication announcement (RPA) because it is not announcing the release of a report but is itself an announcement of a corporate action. Hence, the most appropriate classification is Regulatory Filings (RNS).
2016-03-17 Chinese
第五届监事会第四次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of the company 嘉事堂药业股份有限公司 regarding the use of idle raised funds to temporarily supplement working capital. It includes details of the meeting, voting results, and references a prior announcement of the use of funds. The document is short (778 characters) and is an official announcement of a board decision rather than a full financial report or audit. It does not contain financial statements or detailed financial data. This fits best under the category of Capital/Financing Update (CAP), as it relates to the use of raised funds and capital management.
2016-03-17 Chinese
独立董事关于使用闲置募集资金暂时补充流动资金的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the temporary use of idle raised funds to supplement working capital. It references compliance with company articles, fundraising management systems, and relevant regulatory guidelines. The document is a formal statement of independent directors' approval and opinion on a specific financial decision, not a full financial report or earnings release. It is not an announcement of a report publication but a governance-related opinion. Therefore, it fits best under Board/Management Information (MANG), as it relates to board-level decisions and opinions on company financial management.
2016-03-17 Chinese
第五届董事会第三次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's fifth board of directors' third meeting. It details the approval of a proposal related to the replacement of self-raised funds with raised funds for an investment project. The document includes voting results and references to related announcements published elsewhere. It does not contain full financial statements or detailed financial performance data, nor is it a transcript or presentation. The document is an official announcement of board decisions, specifically about financing activities related to capital use. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and focused on a specific financing decision, not a full report or regulatory filing. Confidence is high due to clear content and context.
2016-03-11 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.